Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

FDA HQ

General Medicine

Second Booster Dose Authorized to Increase Protection Against COVID-19 for Certain People

By

Diana Ernst, RPh

March 30, 2022

The Emergency Use Authorization was based on safety and immunogenicity data provided to the Agency.

nasal polyps illustration

FDA Needs More Data to Decide on Benralizumab for Nasal Polyposis

By

Diana Ernst, RPh

March 25, 2022

The sBLA includes data from the phase 3 OSTRO study, which showed that treatment with subcutaneously administered benralizumab led to statistically significant improvements.

FDA Tells Philips Respironics to Increase Awareness of Product Recall

By

Diana Ernst, RPh

March 21, 2022

The Agency issued the notification order as it deemed the Company’s notification efforts to be inadequate.

General Medicine

FDA Provides List of At-Home OTC COVID-19 Diagnostic Tests

By

Diana Ernst, RPh

March 9, 2022

A list of FDA authorized COVID-19 home tests.

General Medicine

Millions of Courses of Molnupiravir Delivered; HHS Sets Up COVID-19 Therapeutics Locator

By

Diana Ernst, RPh

February 18, 2022

Molnupiravir is an orally administered form of a ribonucleoside analogue that inhibits the replication of SARS-CoV-2.

General Medicine

FDA Approves Second COVID-19 Vaccine Spikevax

By

Diana Ernst, RPh

February 2, 2022

Findings from an ongoing randomized, placebo-controlled, observer-blind phase 3 trial showed Spikevax was 93.2% effective at preventing COVID-19.

General Medicine

Oral Antiviral Treatments for COVID-19: Molnupiravir and Paxlovid

By

Diana Ernst, RPh

January 26, 2022

Concise drug information for molnupiravir and Paxlovid; the FDA granted Emergency Use to both oral antiviral therapies.

General Pulmonology

Contraindication Added to Janssen COVID-19 Vaccine Fact Sheet

By

Diana Ernst, RPh

December 22, 2021

Cases of TTS have been reported in both males and females.

Inhaled Corticosteroids May Reduce Severity, Frequency of Recurrent Croup

By

Diana Ernst, RPh

October 21, 2021

Patients who had more than 5 episodes of croup were more likely to benefit from inhaled corticosteroids.

Otolaryngology-Related Side Effects Following E-Cigarette Use Identified

By

Diana Ernst, RPh

October 4, 2021

The study authors identified 32 studies that reported on side effects following e-cigarette use.

Next post in Smoking

Smoking Has Causal Effect on Risk for Severe COVID-19